SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-138767
Filing Date
2024-12-20
Accepted
2024-12-20 06:59:28
Documents
16
Period of Report
2024-12-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K engn-20241220.htm   iXBRL 8-K 51418
2 EX-1.1 engn-ex1_1.htm EX-1.1 344036
3 EX-5.1 engn-ex5_1.htm EX-5.1 16043
4 GRAPHIC img93391562_0.jpg GRAPHIC 6156
5 GRAPHIC img93391562_1.jpg GRAPHIC 6156
6 GRAPHIC img93391562_2.jpg GRAPHIC 2501
  Complete submission text file 0000950170-24-138767.txt   642983

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT engn-20241220.xsd EX-101.SCH 45681
18 EXTRACTED XBRL INSTANCE DOCUMENT engn-20241220_htm.xml XML 6496
Mailing Address 4868 RUE LEVY, SUITE 220 SAINT-LAURENT A8 H4R 2P1
Business Address 4868 RUE LEVY, SUITE 220 SAINT-LAURENT A8 H4R 2P1 (514) 332-4888
enGene Holdings Inc. (Filer) CIK: 0001980845 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1031
Type: 8-K | Act: 34 | File No.: 001-41854 | Film No.: 241565081
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)